Creotech Instruments (CRI) Q3 2024 earnings summary

Executive summary

• Revenue for the nine months ended September 30, 2024, was PLN 23.0 million, down PLN 10.2 million year-over-year, mainly due to lower product sales and grants income.

• Net loss for the period was PLN 14.5 million, compared to a net loss of PLN 9.3 million in the prior year period.

• Key operational events included the successful launch and initial operation of the EagleEye satellite, followed by communication issues, and the signing of significant contracts with the European Space Agency (ESA).

Financial highlights

• Product sales: PLN 15.5 million (down from PLN 22.5 million year-over-year).

• Grants income: PLN 7.5 million (down from PLN 10.7 million year-over-year).

• Operating expenses: PLN 40.1 million (down from PLN 43.7 million year-over-year).

• Net cash flow from operations: PLN 12.4 million; net cash outflow from investing: PLN -14.6 million; net cash outflow from financing: PLN -2.6 million.

• Total assets at September 30, 2024: PLN 158.9 million (down from PLN 172.5 million at year-end 2023).

• Equity at September 30, 2024: PLN 76.8 million (down from PLN 91.4 million at year-end 2023).

Outlook and guidance

• Future results are highly dependent on the timing of project milestones and sales, component availability, and the phase of R&D projects.

• Inflation, wage pressure, and currency fluctuations are expected to impact costs and margins.